Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Dr. Justin Faden Discusses Treatment-Resistant Schizophrenia

View All News

Justin B. Faden, DO

Justin B. Faden, DOAssistant Professor of Psychiatry & Behavioral Science at the Lewis Katz School of Medicine at Temple University, contributed comments to Psychiatry Advisor for an article about schizophrenia. Dr. Faden was quoted regarding research on treatment-resistant schizophrenia and the need for more uniform diagnostic criteria with real-world applications.